Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial.
Serruys PW, Ong AT, van Herwerden LA, Sousa JE, Jatene A, Bonnier JJ, Schönberger JP, Buller N, Bonser R, Disco C, Backx B, Hugenholtz PG, Firth BG, Unger F. Serruys PW, et al. Among authors: buller n. J Am Coll Cardiol. 2005 Aug 16;46(4):575-81. doi: 10.1016/j.jacc.2004.12.082. J Am Coll Cardiol. 2005. PMID: 16098418 Free article. Clinical Trial.
Five year clinical effect of coronary stenting and coronary artery bypass grafting in renal insufficient patients with multivessel coronary artery disease: insights from ARTS trial.
Aoki J, Ong AT, Hoye A, van Herwerden LA, Sousa JE, Jatene A, Bonnier JJ, Schönberger JP, Buller N, Bonser R, Lindeboom W, Unger F, Serruys PW. Aoki J, et al. Among authors: buller n. Eur Heart J. 2005 Aug;26(15):1488-93. doi: 10.1093/eurheartj/ehi288. Epub 2005 Apr 28. Eur Heart J. 2005. PMID: 15860519 Clinical Trial.
Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease.
Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier HJ, Schönberger JP, Buller N, Bonser R, van den Brand MJ, van Herwerden LA, Morel MA, van Hout BA; Arterial Revascularization Therapies Study Group. Serruys PW, et al. Among authors: buller n. N Engl J Med. 2001 Apr 12;344(15):1117-24. doi: 10.1056/NEJM200104123441502. N Engl J Med. 2001. PMID: 11297702 Free article. Clinical Trial.
Effectiveness and safety of a single intravenous bolus injection of tissue-type plasminogen activator in acute myocardial infarction. Bolus Dose-Escalation Study of Tissue-Type Plasminogen Activator (BEST) Investigators.
Hackett D, Andreotti F, Haider AW, Brunelli C, Shahi M, Fussell A, Buller N, Foale R, Lipkin D, Caponnetto S, et al. Hackett D, et al. Among authors: buller n. Am J Cardiol. 1992 Jun 1;69(17):1393-8. doi: 10.1016/0002-9149(92)90888-6. Am J Cardiol. 1992. PMID: 1590225
108 results